Skip to main content
. 2020 May 19;14:390. doi: 10.3389/fnins.2020.00390

TABLE 2.

Average daily glucose, Ketone, GKI, and BMI values at baseline, 1 month and end of study in eight patients with evaluable data.

Baseline
30 Days
End of study5
ID Glucose (mM) Ketones (mM) GKI1 BMI2 (mg/kg2) Glucose (mM) Ketones (mM) GKI1 BMI (mg/kg2) Glucose (mM) Ketones (mM) GKI1 BMI (mg/kg2)
A 5.1 0.9 5.7 29.4 4.7 2.3 2.1 28.5 4.4 1.0 4.4 26.9
B3 4.8 0.6 8.0 25.3 5.1 3.8 1.3 23.8 5.8 1.1 5.3 23.4
C4 4.9 0.7 7.0 24.5 3.9 2.3 1.7 23.4 4.6 2.7 1.7 23.1
D3 4.1 0.2 20.5 31.6 4.1 4.3 0.95 31 5.4 0.9 6.0 30.1
E 3.9 1.4 2.8 26.9 5.5 2.3 2.4 25.5 4.7 1.9 2.5 25.5
F2 5.5 4.2 1.3 24 4.5 3.2 1.4 22.7 5.0 3.0 1.7 21.0
G 5.8 0.2 28.8 21.6 4.9 1.7 2.9 21.1 5.2 1.7 3.1 18.7
H 3.7 5.5 0.67 21.3 4.1 4.4 0.93 26.9 3.8 1.5 2.6 21.1

1GKI (Glucose Ketone Index), where GKI < 1, therapeutic ketosis; GKI 1-3, high ketosis; GKI 3-6, moderate ketosis; GKI 6-9, low ketosis; GKI > 9 no ketosis. 2BMI (body mass index). 3Patients B and D were on steroids. 4Patients C and F were already on pre-keto diet when starting data collection used for case series. 5Day 120, or on last day available data for individual patient if 120 days not reached.